Similarly, tumor-implanted mice that received RT + aPD-1 treatment showed a 58% decrease in BrdU/NeuN positive cells compared to sham saline mice (Fig. 4A,B, P < 0.001). The gene discussed is RBFOX3; the disease is neoplasm.